← Leaderboards
Keith Thomas Gagnon
Southern Illinois University Carbondale
$5,999,933
Attributed
$5,999,933
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,999,933 · 10
By mechanism
R61$1,785,797 · 1
R21$1,638,073 · 4
R01$1,115,733 · 1
R33$703,727 · 1
R15$442,500 · 1
R03$161,625 · 1
Top collaborators
No co-investigators on record.
Most similar at Southern Illinois University Carbondale
Same institution · by research overlap
- Vjollca H Konjufca$1,090,310
- Punit Kohli$633,192
- Judith Kimberly Davie$1,227,750
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsPharmaceutical PreparationsProteinsGeneticDesignNucleic AcidsBindingEnzymesIn VitroPropertyGenesMediatingGenetic TranscriptionGene ExpressionModificationChemistryMutantBaseGuide RnaProductionTranslationsAnimal ModelGenomeMethodology
Grant awards (22)
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection$703,727
R33 · FY2025 · AI · contact PI
Enabling Focused Ultrasound-Activated Gene Editing with Thermo-Controlled CRISPR-Cas9$421,811
R21 · FY2025 · GM · contact PI
Toward a Curative Treatment for HBV with cccDNA-Targeting Peptide Nucleic Acids$211,418
R21 · FY2025 · AI · contact PI
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection$534,319
R61 · FY2024 · AI · contact PI
Toward synthetic chemically defined mRNA for human therapeutics$230,891
R21 · FY2024 · GM · contact PI
Toward a Curative Treatment for HBV with cccDNA-Targeting Peptide Nucleic Acids$180,537
R21 · FY2024 · AI · contact PI
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection$348,314
R61 · FY2023 · AI · contact PI
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection$248,808
R61 · FY2023 · AI · contact PI
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9$241,926
R01 · FY2023 · GM · contact PI
Toward synthetic chemically defined mRNA for human therapeutics$205,541
R21 · FY2023 · GM · contact PI
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9$52,772
R01 · FY2023 · GM · contact PI
Coupling Epitranscriptomics to Molecular Disease Mechanisms and Nucleic Acid Therapeutics in Persistent Residual HIV Infection$654,356
R61 · FY2022 · AI · contact PI
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9$269,720
R01 · FY2022 · GM · contact PI
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9$269,720
R01 · FY2021 · GM · contact PI
Inhibiting C9ORF72 Repeat RNA Transcription with a Common Class of Small Molecules$387,875
R21 · FY2020 · NS · contact PI
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9$281,595
R01 · FY2020 · GM · contact PI
Discovery of Small Molecules that Block Supt4h1-Supt5h Dimerization for Potential C9FTD/ALS Therapeutics$73,750
R03 · FY2020 · NS · contact PI
Nuclear Surveillance of Expanded Tandem Repeat RNA in C9FTD/ALS Disease$442,500
R15 · FY2019 · NS · contact PI
Discovery of Small Molecules that Block Supt4h1-Supt5h Dimerization for Potential C9FTD/ALS Therapeutics$87,875
R03 · FY2019 · NS · contact PI
Activating Gene Expression with Antigene RNAs to Treat Genetic Diseases$53,942
F32 · FY2012 · HD · contact PI
Activating Gene Expression with Antigene RNAs to Treat Genetic Diseases$51,326
F32 · FY2011 · HD · contact PI
Activating Gene Expression with Antigene RNAs to Treat Genetic Diseases$47,210
F32 · FY2009 · HD · contact PI